These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2025109)

  • 1. [Experimental and clinical studies of drug regulation of the anti-lysozyme activity of microorganisms causing opportunistic infections].
    Bukharin OV; Usviatsov BIa; Pervushina LA; Zaikina OL; Rishchuk SV; Surikova EV; Sheenkov NV
    Antibiot Khimioter; 1991 Feb; 36(2):14-7. PubMed ID: 2025109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic sensitivity of the main opportunistic pathogenic aerobic bacteria].
    Minukhin VV; Tsyganenko AIa; Kravtsova VI; Arkushenko LL; Stepanenko TV
    Antibiot Khimioter; 1990 Mar; 35(3):36-8. PubMed ID: 2113800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary microflora and rational antibiotic therapy in pyelonephritis].
    Peskina LS; Bogach IE; Karpushkina ON
    Pediatriia; 1991; (7):109. PubMed ID: 1754313
    [No Abstract]   [Full Text] [Related]  

  • 4. Biovaluation of the antibacterial flumequine for enteric use.
    Rohlfing SR; Gerster JF; Kvam DC
    J Antimicrob Chemother; 1977 Nov; 3(6):615-20. PubMed ID: 340442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacterial antilysozyme activity and its regulation by antibiotics].
    Bukharin OV; Usiatsov BIa; Zykova LS; Malyshkin AP; Pervushina LA
    Antibiot Med Biotekhnol; 1987 Aug; 32(8):597-602. PubMed ID: 3674841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASM Microbe 2017.
    McConnell J
    Lancet Infect Dis; 2017 Jul; 17(7):699. PubMed ID: 28737492
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selection of antibodies for the treatment of biliary tract infections].
    Kalemba M; Kluczyński S; Nowicka B
    Wiad Lek; 1981 Mar; 34(6):471-4. PubMed ID: 7023069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitization of lymphocytes from newborn infants and young children to pathogenic and opportunistic microflora].
    Gavrilova LO; Autenshlius AI
    Pediatriia; 1990; (10):33-8. PubMed ID: 2284175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aztreonam].
    Iakovlev VP
    Antibiot Khimioter; 1992 Aug; 37(8):49-56. PubMed ID: 1456829
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007.
    Decousser JW; Lamy B; Pina P; Allouch PY;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):292-300. PubMed ID: 19903587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary studies with nebramycin factor 6.
    Black HR; Griffith RS
    Antimicrob Agents Chemother (Bethesda); 1970; 10():314-21. PubMed ID: 5521350
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial use prior to the acquisition of multiresistant bacteria.
    Eveillard M; Schmit JL; Eb F
    Infect Control Hosp Epidemiol; 2002 Mar; 23(3):155-8. PubMed ID: 11918124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rational antimicrobial therapy of chronic bacterial prostatitis].
    Popov SV
    Antibiot Khimioter; 2013; 58(5-6):32-7. PubMed ID: 24757823
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance and molecular epidemiology of aerobic bacteria isolated from puerperal infections in Bangladesh.
    Ahmed S; Kawaguchiya M; Ghosh S; Paul SK; Urushibara N; Mahmud C; Nahar K; Hossain MA; Kobayashi N
    Microb Drug Resist; 2015 Jun; 21(3):297-306. PubMed ID: 25555043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of bacteria to antibiotics in urinary tract infection].
    Mróz E; Gościniak G; Ruczkowska J; Grzybek-hryncewicz K; Choroszy I
    Wiad Lek; 1981 Jul; 34(13):1085-9. PubMed ID: 6795830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the automated system for bacteriological diagnosis of suppurative complications].
    Imshenetskaia VF
    Antibiot Khimioter; 1990 Oct; 35(10):41-3. PubMed ID: 2278498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary lysozyme activity in acute urinary tract infections in children].
    Ziobro J; Kralisz R; Podkowicz K; Siwicka-Szmitkowska K; Prokopowicz J
    Pediatr Pol; 1980 Jun; 55(6):739-42. PubMed ID: 7413323
    [No Abstract]   [Full Text] [Related]  

  • 18. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
    Conlon BP
    Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical study of the use of lysozyme in combination with chemotherapeutic agents].
    Bukharin OV; Zykova LS; Tarasenko NF
    Antibiot Med Biotekhnol; 1986 Dec; 31(12):917-20. PubMed ID: 3566222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.